Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"

Phase 3 Completed 236 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd Ewha Womans University · collab Hanyang University · collab Inha University Hospital · collab Konkuk University Medical Center · collab Kyunghee University Medical Center · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess therapeutic confirmation of AG NPP709 syrup to evaluate the safety and efficacy in patients with acute upper respiratory tract infection and chronic inflammatory bronchitis.

Timeline

Start: 2010-02
Primary completion: 2010-05
Completion: 2010-06

Outcome

Met primary endpoint

paper AG NPP709 was non-inferior to ivy leaf extract PMID 41807028 ↗

paper between-group difference of 4.3% (95% confidence interval: -8.9, 17.5). PMID 41807028 ↗

Publications

Cho YJ, Yoon HJ, Lim DH, Yoo KH, Choi SH, Rha YH. Randomized, Double-Blind, Multicenter, Phase 3 Study of AG NPP709 Compared With Ivy Leaf Extract in Patients With Acute or Chronic Respiratory Symptoms. J Korean Med Sci. 2026 Mar 9;41(9):e97. doi: 10.3346/jkms.2026.41.e97.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AG NPP709	Unknown	—	—